BORMANN-KENNEDY BARBARA-JEAN ANNE received a stock award from XERIS BIOPHARMA HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/9/2022ACC: 0001867096-22-000094
Director
Since Oct 2021
+40K
Net shares
Net buyer
$31.5K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
40K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+15K
Price / share
$2.10
Trade value
$31.50K
% of position
New position
6/8/2022
0.00→15K
Total
Net shares
+15K
Net value
$31.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/8/2022 | A · Award | +15K | $2.10 | $31.50K | New position | 0.00 | 15K |
| Total | +15K | $31.50K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
25K shares
Shares
+25K
Strike price
2.1
Held after
25K
Exercisable
—
6/8/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock25K shares | 6/8/2022 | A · Award | +25K | 2.1 | — | 25K |